Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration

Daniel J. Cooper, Giulia Zunino, John Bixby, Vance Lemmon

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

High-throughput, target-based screening techniques have been utilized extensively for drug discovery in the past several decades. However, the need for more predictive . in vitro models of . in vivo disease states has generated a shift in strategy towards phenotype-based screens. Phenotype based screens are particularly valuable in studying complex conditions such as CNS injury and degenerative disease, as many factors can contribute to a specific cellular response. In this review, we will discuss different screening frameworks and their relative utility in examining mechanisms of neurodegeneration and axon regrowth, particularly in cell-based . in vitro disease models.

Original languageEnglish (US)
JournalMolecular and Cellular Neuroscience
DOIs
StateAccepted/In press - Apr 25 2016

Fingerprint

Regeneration
Neurons
Pharmaceutical Preparations
Phenotype
Drug Discovery
Axons
Wounds and Injuries
In Vitro Techniques

Keywords

  • Axon degeneration
  • Axon growth
  • Axon regeneration
  • High content analysis
  • High throughput screening
  • Phenotypic analysis

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

@article{4b4c010feac64681af8b32c3f9af17f0,
title = "Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration",
abstract = "High-throughput, target-based screening techniques have been utilized extensively for drug discovery in the past several decades. However, the need for more predictive . in vitro models of . in vivo disease states has generated a shift in strategy towards phenotype-based screens. Phenotype based screens are particularly valuable in studying complex conditions such as CNS injury and degenerative disease, as many factors can contribute to a specific cellular response. In this review, we will discuss different screening frameworks and their relative utility in examining mechanisms of neurodegeneration and axon regrowth, particularly in cell-based . in vitro disease models.",
keywords = "Axon degeneration, Axon growth, Axon regeneration, High content analysis, High throughput screening, Phenotypic analysis",
author = "Cooper, {Daniel J.} and Giulia Zunino and John Bixby and Vance Lemmon",
year = "2016",
month = "4",
day = "25",
doi = "10.1016/j.mcn.2016.07.001",
language = "English (US)",
journal = "Molecular and Cellular Neuroscience",
issn = "1044-7431",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration

AU - Cooper, Daniel J.

AU - Zunino, Giulia

AU - Bixby, John

AU - Lemmon, Vance

PY - 2016/4/25

Y1 - 2016/4/25

N2 - High-throughput, target-based screening techniques have been utilized extensively for drug discovery in the past several decades. However, the need for more predictive . in vitro models of . in vivo disease states has generated a shift in strategy towards phenotype-based screens. Phenotype based screens are particularly valuable in studying complex conditions such as CNS injury and degenerative disease, as many factors can contribute to a specific cellular response. In this review, we will discuss different screening frameworks and their relative utility in examining mechanisms of neurodegeneration and axon regrowth, particularly in cell-based . in vitro disease models.

AB - High-throughput, target-based screening techniques have been utilized extensively for drug discovery in the past several decades. However, the need for more predictive . in vitro models of . in vivo disease states has generated a shift in strategy towards phenotype-based screens. Phenotype based screens are particularly valuable in studying complex conditions such as CNS injury and degenerative disease, as many factors can contribute to a specific cellular response. In this review, we will discuss different screening frameworks and their relative utility in examining mechanisms of neurodegeneration and axon regrowth, particularly in cell-based . in vitro disease models.

KW - Axon degeneration

KW - Axon growth

KW - Axon regeneration

KW - High content analysis

KW - High throughput screening

KW - Phenotypic analysis

UR - http://www.scopus.com/inward/record.url?scp=84996479969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996479969&partnerID=8YFLogxK

U2 - 10.1016/j.mcn.2016.07.001

DO - 10.1016/j.mcn.2016.07.001

M3 - Article

JO - Molecular and Cellular Neuroscience

JF - Molecular and Cellular Neuroscience

SN - 1044-7431

ER -